Biohit
2.40 EUR
+3.00 %
4,928 following
Corporate customer
BIOBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Biohit
| Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26e | Q2/26e | Q3/26e | Q4/26e | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.4 | 8.3 | 15.7 | 8.0 | 9.0 | ||||
| EBITDA | 1.4 | 2.0 | 3.4 | 1.4 | 1.7 | ||||
| EBIT (adj.) | 1.2 | 1.7 | 2.9 | 1.1 | 1.5 | ||||
| EBIT | 1.2 | 1.7 | 2.9 | 1.1 | 1.5 | ||||
| EBIT-% (adj.) | 16.2 % | 20.5 % | 18.5 % | 14.2 % | 16.5 % | ||||
| EBIT-% | 16.2 % | 20.5 % | 18.5 % | 14.2 % | 16.5 % | ||||
| Profit before taxes | 1.2 | 1.7 | 2.9 | 1.2 | 1.6 | ||||
| Net income | 1.0 | 1.7 | 2.7 | 0.9 | 1.3 |